Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Corium, StrataGent merge:

This article was originally published in Clinica

Executive Summary

Transdermal technology specialist Corium International is to merge with StrataGent Life Sciences, a fellow drug delivery company, as part of a $25.1m series C financing. The round was led by Essex Woodlands Health Ventures, which was an investor in StrataGent. The proceeds from the fundraising will be used to develop products based on Corium's MicroCor microneedle and Corplex polymer adhesive technologies, and on StrataGent's liquid microjet drug delivery platform. Robert Thomas, currently CEO of StrataGent and former CEO of FoxHollow Technologies, will serve as CEO of the combined company, while Ron Eastman of Essex Woodlands will become the company's chairman. Corium co-founder Gary Cleary and StrataGent co-founder Ravi Srinivasan will join the board of directors. StrataGent will relocate to Corium's headquarters in Menlo Park, California.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049984

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel